Akebia Therapeutics Inc (NASDAQ:AKBA)

0.5634
Delayed Data
As of Mar 30
 -0.0418 / -6.91%
Today’s Change
0.24
Today|||52-Week Range
2.34
-2.36%
Year-to-Date
No recent news for Akebia Therapeutics Inc.

Today’s Trading

Previous close0.61
Today’s open0.60
Day’s range0.55 - 0.61
Volume1,194,704
Average volume (3 months)2,159,966
Market cap$115.6M
Data as of 3:59pm ET, 03/30/2023

Growth & Valuation

Earnings growth (last year)+70.29%
Earnings growth (this year)+2.61%
Earnings growth (next 5 years)+15.80%
Revenue growth (last year)+37.00%
P/E ratioNM
Price/Sales0.36
Price/Book12.37

Competitors

 Today’s
change
Today’s
% change
SLGLSol Gel Technologies...-0.17-4.05%
----
MNOVMediciNova Inc-0.02-0.92%
DRRXDURECT Corp0.000.00%
Data as of 3:59pm ET, 03/30/2023

Financials

Next reporting dateMay 8, 2023
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$292.6M
Annual profit (last year)-$92.6M
Net profit margin-31.63%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Cambridge, Massachusetts

Forecasts